These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Necrotizing fasciitis of the eyelids and toxic shock syndrome due to Streptococcus pyogenes]. Bustos B R; Soto G G; Hickmann O L; Torres B C Rev Chilena Infectol; 2009 Apr; 26(2):152-5. PubMed ID: 19621147 [TBL] [Abstract][Full Text] [Related]
44. Streptococcal toxic shock syndrome complicating varicella in children. Yang YJ; Liu CC; Wang SM; Huang CC; Wu JJ J Formos Med Assoc; 1997 Sep; 96(9):749-53. PubMed ID: 9308331 [TBL] [Abstract][Full Text] [Related]
45. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics. Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377 [TBL] [Abstract][Full Text] [Related]
48. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1. Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671 [TBL] [Abstract][Full Text] [Related]
49. [Invasive streptococcal infection as a complication of chickenpox]. Geelen SP; de Graeff-Meeder ER Ned Tijdschr Geneeskd; 1998 May; 142(20):1113-6. PubMed ID: 9623230 [TBL] [Abstract][Full Text] [Related]
50. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291 [TBL] [Abstract][Full Text] [Related]
51. Defense against biologic warfare with superantigen toxins. Kaempfer R; Arad G; Levy R; Hillman D Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463 [TBL] [Abstract][Full Text] [Related]
52. Therapeutic considerations for children with invasive group a streptococcal infections: a case series report and review of the literature. Burnett AM; Domachowske JB Clin Pediatr (Phila); 2007 Jul; 46(6):550-5. PubMed ID: 17579110 [No Abstract] [Full Text] [Related]
53. [Superantigens in human disease]. Rojas Ramos E; Cisneros González N; Cairo Cueto SM Rev Alerg Mex; 1997; 44(3):77-82. PubMed ID: 9377117 [TBL] [Abstract][Full Text] [Related]
54. The presence of superantigens and complex host responses in severe sepsis may need a broad therapeutic approach. Stegmayr BG Ther Apher; 2001 Apr; 5(2):111-4. PubMed ID: 11354294 [TBL] [Abstract][Full Text] [Related]
55. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Miethke T; Duschek K; Wahl C; Heeg K; Wagner H Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325 [TBL] [Abstract][Full Text] [Related]
56. Immunoregulatory mechanisms of T-cell-dependent shock induced by a bacterial superantigen in mice. Florquin S; Goldman M Infect Immun; 1996 Sep; 64(9):3443-5. PubMed ID: 8751882 [No Abstract] [Full Text] [Related]
57. [Stimulation of the immune system by microbial "superantigens"]. Fleischer B Immun Infekt; 1991 Feb; 19(1):8-11. PubMed ID: 2060968 [TBL] [Abstract][Full Text] [Related]
58. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1. Buonpane RA; Moza B; Sundberg EJ; Kranz DM J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815 [TBL] [Abstract][Full Text] [Related]
59. Streptococcal toxic shock syndrome in children. Floret D; Stamm D; Cochat P; Delmas P; Kohler W Intensive Care Med; 1992; 18(3):175-6. PubMed ID: 1644967 [TBL] [Abstract][Full Text] [Related]
60. Toxic shock-like syndrome due to streptococcal hand infection. Craigen MA; Wallace WA J R Coll Surg Edinb; 1992 Aug; 37(4):269-70. PubMed ID: 1383531 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]